This topic contains a solution. Click here to go to the answer

Author Question: While assessing a patient before administering neostigmine for the treatment of myasthenia gravis, ... (Read 96 times)

joe

  • Hero Member
  • *****
  • Posts: 627
While assessing a patient before administering neostigmine for the treatment of myasthenia gravis, the nurse notices that the patient has greater muscle strength than when assessed 1 hour ago.
 
  The nurse's interpretation of this assessment information is that:
  1. the dose needs to be increased.
  2. the medication schedule seems to be effective.
  3. the patient will not require the next scheduled dose.
  4. toxicity is impending.

Question 2

When toxicity results from irreversible cholinesterase inhibitors, it is usually a result of:
 
  1. overdose of a prescribed medication.
  2. drug interaction between a prescribed medication and an over-the-counter agent.
  3. poisoning by organophosphates.
  4. a genetic predisposition or lack of a degrading enzyme.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

emily12345

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

Correct Answer: 2

Answer to Question 2

Correct Answer: 3




joe

  • Member
  • Posts: 627
Reply 2 on: Jul 23, 2018
Gracias!


bigsis44

  • Member
  • Posts: 317
Reply 3 on: Yesterday
Excellent

 

Did you know?

Only 12 hours after an egg cell is fertilized by a sperm cell, the egg cell starts to divide. As it continues to divide, it moves along the fallopian tube toward the uterus at about 1 inch per day.

Did you know?

Children of people with alcoholism are more inclined to drink alcohol or use hard drugs. In fact, they are 400 times more likely to use hard drugs than those who do not have a family history of alcohol addiction.

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

For a complete list of videos, visit our video library